Hagens berman, national trial attorneys, encourages co-diagnostics (codx) investors with significant losses to contact the firm's attorneys, securities fraud class action filed

San francisco, aug. 19, 2022 /prnewswire/ -- hagens berman urges co-diagnostics, inc. (nasdaq: codx) investors who suffered significant losses to submit your losses now. class period: may 12, 2022 – aug. 11, 2022 lead plaintiff deadline: oct. 17, 2022 visit: www.hbsslaw.com/investor-fraud/codx contact an attorney now: codx@hbsslaw.com         844-916-0895 co-diagnostics, inc. (nasdaq: codx) securities fraud class action: throughout the class period, defendants repeatedly touted co-diagnostics' logix smart covid-19 test and, as recently as may 12, 2022, reassured investors about the demand for that product.
CODX Ratings Summary
CODX Quant Ranking